Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +6.13% | +0.42% | -22.97% |
May. 14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 38.98M | Sales 2025 * | 95.73M | Capitalization | 165M |
---|---|---|---|---|---|
Net income 2024 * | -60M | Net income 2025 * | -30M | EV / Sales 2024 * | 4.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
-3.02
x | P/E ratio 2025 * |
-6.38
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.87% |
Latest transcript on scPharmaceuticals Inc.
1 day | +5.47% | ||
1 week | -0.21% | ||
Current month | +7.38% | ||
1 month | +2.78% | ||
3 months | -16.38% | ||
6 months | -4.38% | ||
Current year | -23.44% |
Managers | Title | Age | Since |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 14-08-31 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 13-12-31 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 17-11-20 |
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4.83 | +5.69% | 195 603 |
24-05-15 | 4.57 | +1.56% | 828,706 |
24-05-14 | 4.5 | +3.45% | 347,143 |
24-05-13 | 4.35 | -2.90% | 179,735 |
24-05-10 | 4.48 | -6.86% | 112,147 |
Delayed Quote Nasdaq, May 16, 2024 at 01:54 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.44% | 165M | |
+33.02% | 709B | |
+30.77% | 595B | |
-1.83% | 367B | |
+20.23% | 334B | |
+5.70% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.20% | 171B |
- Stock Market
- Equities
- SCPH Stock